Nichtinfektiöse unerwünschte Wirkungen

  • V. Kiefel

Zusammenfassung

Transfusionsreaktionen sind unter verschiedenen Gesichtspunkten klassifizierbar: so könnten Sofortreaktionen von verzögerten Transfusionsreaktionen abgegrenzt werden. Der Einfachheit einer solchen Klassifikation stünde als Nachteil gegenüber, dass sehr heterogene Reaktionen zusammengefasst und ätiologisch eng verwandte Reaktionen getrennt werden müssten. Eine Einteilung kann aber auch aus der zugrundeliegenden Ätiologie abgeleitet werden. Die folgende Beschreibung teilt Transfusionsreaktionen anhand der beobachteten Symptome ein und sie berücksichtigt ätiologische Gesichtpunkte, soweit unsere heutigen Kenntnisse hierzu ausreichen (◘ Tabelle 35. 1). In der Darstellung dieses Kapitels werden diejenigen Bezeichnungen für einzelne Reaktionen und Erkrankungen verwendet, die sich auch in der internationalen Literatur eingebürgert haben.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Anolik JH, Blumberg N, Snider J, Francis CW (2001) Posttransfusion purpura secondary to an alloantibody reactive with HPA-5a (Br(b)). Transfusion 41: 633–636PubMedGoogle Scholar
  2. 2.
    Asai T, Inaba S, Ohto H et. al. (2000) Guidelines for irradiation of blood and blood components to prevent post-transfusion graft- vs. -host disease in Japan. Transfus Med 10: 315–320PubMedGoogle Scholar
  3. 3.
    Ballem PJ, Buskard NA, Decary F, Doubroff P (1987) Post-transfusion purpura secondary to passive transfer of anti-PI(A1) by blood transfusion. Br J Haematol 66: 113–114PubMedGoogle Scholar
  4. 4.
    BCSH blood transfusion task force (1996) Guidelines for gamma irradiation of blood components for the prevention of transfusion-associated graft-vs. -host disease. Transfus Med 6: 261–271Google Scholar
  5. 5.
    Beauregard P, Blajchman MA (1994) Hemolytic and pseudo-hemolytic transfusion reactions: an overview of the hemolytic transfusion reactions and the clinical conditions that mimic them. Transfus Med Rev 8: 184–199PubMedGoogle Scholar
  6. 6.
    Bierling P, Godeau B, Fromont P et al. (1995) Posttransfusion Purpura-like syndrome associated with CD36 (Nak(a)) isoimmunization. Transfusion 35: 777–782PubMedGoogle Scholar
  7. 7.
    Bolan CD, Childs RW, Procter JL et al. (2001) Massive immune haemolysis after allogeneic peripheral blood stem cell transplantation with minor AB0 incompatibility. Br J Haematol 112: 787 – 795PubMedGoogle Scholar
  8. 8.
    Brubaker DB (1992) Pathogenesis and diagnosis of posttransfusion graft-vs-host disease. In: Baldwin ML, Jeffries LC (eds) Irradiation of blood components, 1st edn. American Association of Blood Banks, Bethesda, pp 1–30Google Scholar
  9. 9.
    Brunner-Bollinger S, Kiefel V, Horber FF et al. (1997) Antibody studies in a patient with acute thrombocytopenia following infusion of plasma containing anti-PI(A1). Am J Hematol 56: 119–121Google Scholar
  10. 10.
    Buren NLV, Stroncek DF, Clay ME et. al (1990) Transfusion-related acute lung injury caused by an NB2 granulocyte-specific antibody in a patient with thrombotic thrombocytopenic purpura. Transfusion 30: 42–45PubMedGoogle Scholar
  11. 11.
    Burks AW, Sampson HA, Buckley RH (1986) Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia. Detection of lgE antibodies to lgA. N Engl J Med 314: 560–564PubMedGoogle Scholar
  12. 12.
    Butler J, Parker D, Pillai R et. al (1991) Systemic release of neutrophil elastase and tumour necrosis factor alpha following AB0 incompatible blood transfusion. Br J Haematol 79: 525–526PubMedGoogle Scholar
  13. 13.
    Bux J, Becker F, Seeger W et. al. (1996) Transfusion-related acute lung injury due to anti-HLA-A2-specific antibodies in recipient and NB1-specific antibodies in donor blood. Br J Haematol 93: 707–713PubMedGoogle Scholar
  14. 14.
    Capon SM, Goldfinger D (1995) Acute hemolytic transfusion reaction, a paradigm of the systemic inflammatory response: new insights into pathophysiology and treatment. Transfusion 35: 513 – 520PubMedGoogle Scholar
  15. 15.
    Christie DJ, Pulkrabek S, Putnam JL et al. (1991) Posttransfusion purpura due to an alloantibody reactive with glycoprotein la/IIa (anti-HPA-5b). Blood 77: 2785–2789PubMedGoogle Scholar
  16. 16.
    Conway LT, Scott EP (1984) Acute hemolytic transfusion reaction due to AB0 incompatible plateletapheresis concentrate. Transfusion 24: 413–414PubMedGoogle Scholar
  17. 17.
    Croucher BEE, Crookston MC und Crookston JH (1967) Delayed haemolytic transfusion reaction simulating auto-immune haemolytic anemia. Vox Sanguinis 12: 32–42Google Scholar
  18. 18.
    Davenport RD (1996) Cytokines as intercellular signals in hemolytic transfusion reactions. Biol Sign 5: 240–245Google Scholar
  19. 19.
    Davenport RD, Burdick MD, Strieter RM, Kunkel SL (1994) In vitro production of interleukin-1 receptor antagonist in lgG-mediated red cell incompatibility. Transfusion 34: 297–303PubMedGoogle Scholar
  20. 20.
    Davenport RD, Kunkel SL (1994) Cytokine roles in hemolytic and nonhemolytic transfusion reactions. Transfus Med Rev 8: 157–168PubMedGoogle Scholar
  21. 21.
    Davenport RD, Polak TJ, Kunkel SL (1994) White cell-associated procoagulant activity induced by AB0 incompatibility. Transfusion 34: 943–949PubMedGoogle Scholar
  22. 22.
    Davenport RD, Strieter RM, Kunkel SL (1991) Red cell AB0 incompatibility and production of tumour necrosis factor-alpha. Br J Haematol 78: 540–544PubMedGoogle Scholar
  23. 23.
    Davenport RD, Strieter RM, Standiford TJ, Kunkel SL (1990) Interleukin-8 production in red blood cell incompatibility. Blood 76: 2439–2442PubMedGoogle Scholar
  24. 24.
    de Rie MA, van der Plas-van Dalen CM, Engelfriet CP, von dem Borne AE (1985) The serology of febrile transfusion reactions. Vox Sanguinis 49: 126–134PubMedGoogle Scholar
  25. 25.
    Decary F, Ferner P, Giavedoni L et al. (1984) An investigation of nonhemolytic transfusion reactions. Vox Sanguinis 46: 277–285PubMedGoogle Scholar
  26. 26.
    Dieleman LA, Brand A, Claas FHJ et al. (1989) Acquired Zw(a) antigen on Zw(a) negative platelets demonstrated by Western blotting. Br J Haematol 72: 539–542PubMedGoogle Scholar
  27. 27.
    Dinarello CA, Cannon JG, Wolff SM et al. (1986) Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 163: 1433–1450PubMedGoogle Scholar
  28. 28.
    Eastlund T, McGrath PC, Britten A, Propp R (1989) Fatal pulmonary transfusion reaction to plasma containing donor HLA antibody. Vox Sanguinis 57: 63–66PubMedGoogle Scholar
  29. 29.
    Engelfriet CP, Reesink HW, Brand A et al. (2001) International forum. Transfusion-related acute lung injury (TRALI). Vox Sanguinis 81: 269–283PubMedGoogle Scholar
  30. 30.
    Felix CA, Davey RJ (1987) Massive acute hemolysis secondary to Clostridium perfringens sepsis in a recently transfused oncology patient with multiple alloantibodies. Medical and Pediatric Oncology 15: 42–44PubMedGoogle Scholar
  31. 31.
    Flesch BK, Neppert J (2002) Transfusion-related acute lung injury caused by human leucocyte antigen class II antibody. Br J Haematol 116: 673–676PubMedGoogle Scholar
  32. 32.
    Friedman HD, Noonan M (1996) Acute gram-negative urosepsis mimicking an acute hemolytic transfusion reaction. Transfusion 36: 460–462PubMedGoogle Scholar
  33. 33.
    Gabutti V, Borgna-Pignatti C (1994) Clinical manifestations and therapy of transfusional haemosiderosis. Baillière’s Clin Haematol 7: 919–940Google Scholar
  34. 34.
    Gerstner JB, Smith MJ, Davis KD et al. (1979) Posttransfusion purpura: therapeutic failure of PI(A1)-negative platelet transfusion. Am J Hematol 6: 71–75PubMedGoogle Scholar
  35. 35.
    Giardina PJ, Grady RW (1995) Chelation therapy in beta-thalassemia: the benefits and limitations of desferoxamine. Semin Hematol 32: 304–312PubMedGoogle Scholar
  36. 36.
    Hamblin TJ, Abidi SMN, Nee PA et al. (1985) Successful treatment of post-transfusion purpura with high dose immunoglobulins after lack of response to plasma exchange. Vox Sanguinis 49: 164–167PubMedGoogle Scholar
  37. 37.
    Harrington WJ, Minnich V, Hollingsworth JW, Moore CV (1951) Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med 38: 1–10PubMedGoogle Scholar
  38. 38.
    Heddle NM, Klama L, Singer J et al. (1994) The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med 331: 625–628PubMedGoogle Scholar
  39. 39.
    Holland PV, Wallerstein RO (1968) Delayed hemolytic transfusion reaction with acute renal failure. J Am Med Assoc 204: 1007–1008Google Scholar
  40. 40.
    Issitt PD, Combs MR, Bumgamer DJ et al. (1996) Studies of antibodies in the sera of patients who have made red cell autoantibodies. Transfusion 36: 481–486PubMedGoogle Scholar
  41. 41.
    Kaltwasser JP (1996) Eisenstoffwechsel. In: Mueller-Eckhardt C (Hrsg) Transfusionsmedizin. Grundlagen, Therapie, Methodik, 2. Aufl. Springer, Berlin, Heidelberg New York Tokio, S 113–124Google Scholar
  42. 42.
    Kernoff PBA, Durant IJ, Rizza CR, Wright FW (1972) Severe allergic pulmonary oedema after plasma transfusion. Br J Haematol 23: 777–781PubMedGoogle Scholar
  43. 43.
    Kersten MJ, Lange R, Smeets MEP et al. (1996) Long-term treatment of transfusional iron overload with the iron chelator deferiprone (L1): a Dutch multicenter trial. Ann Hematol 73: 247–252PubMedGoogle Scholar
  44. 44.
    Kiefel V (1992) The MAIPA assay and its applications in immunohematology. Transfus Med 2: 181–188PubMedGoogle Scholar
  45. 45.
    Kiefel V, Santoso S, Weisheit M und Mueller-Eckhardt C (1987) Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet reactive antibodies. Blood 70: 1722–1726PubMedGoogle Scholar
  46. 46.
    King KE, Shirey RS, Lankiewicz MW et al. (1997) Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients‹ red cells. Transfusion 37: 376–381PubMedGoogle Scholar
  47. 47.
    Kopko PM, Holland PV (1999) Transfusion-related acute lung injury. Br J Haematol 105: 322–329PubMedGoogle Scholar
  48. 48.
    Kroll H, Kiefel V, Mueller-Eckhardt C (1993) Posttransfusionelle Purpura: Klinische und immunologische Untersuchungen bei 38 Patientinnen. Infusionsther Transfusionsmed 20: 198–204PubMedGoogle Scholar
  49. 49.
    Larsson LG, Welsh VJ, Ladd DJ (2000) Acute intravascular hemolysis secondary to out-of-group platelet transfusion. Transfusion 40: 902–906PubMedGoogle Scholar
  50. 50.
    Laschinger C, Shepherd FA, Naylor DH (1984) Anti-lgA-mediated transfusion reactions in Canada. Can Med Assoc J 130: 141–144PubMedGoogle Scholar
  51. 51.
    Leach M, Vora AJ, Jones DA, Lucas G (1998) Transfusion-related acute lung injury (TRALI) following autologous stem cell transplant for relapsed acute myeloid leukaemia: a case report and review of the literature. Transfus Med 8: 333–337PubMedGoogle Scholar
  52. 52.
    Leo A, Mytilineos J, Voso MT et al. (2000) Passenger lymphocyte syndrome with severe hemolytic anemia due to an anti-Jk(a) after allogeneic PBPC transplantation. Transfusion 40: 632–636PubMedGoogle Scholar
  53. 53.
    Linden JV (1999) Errors in transfusion medicine. Scope of the problem. Arch Pathol Lab Med 123: 563–565PubMedGoogle Scholar
  54. 54.
    Linden JV, Kaplan HS und Murphy MT (1997) Fatal air embolism due to perioperative blood recovery. Anesth Analg 84: 422–426PubMedGoogle Scholar
  55. 55.
    Linden JV, Paul B, Dressler KP (1992) A report of 104 transfusion errors in New York State. Transfusion 32: 601–606PubMedGoogle Scholar
  56. 56.
    Love EM, Jones H, Williamson LM et al. (2001) Serious hazards of transfusion. Annual report 1999–2000. http://www.shotdemon.co.uk Google Scholar
  57. 57.
    Lucas G, Rogers S, Evans R et al. (2000) Transfusion-related acute lung injury associated with interdonor incompatibility for the neutrophil-specific antigen HNA-1a. Vox Sanguinis 79: 112–115PubMedGoogle Scholar
  58. 58.
    Mair B, Benson K (1998) Evaluation of changes in hemoglobin levels associated with AB0-incompatible plasma in apheresis platelets. Transfusion 38: 51–55PubMedGoogle Scholar
  59. 59.
    McManigal S, Sims KL (1999) Intravascular hemolysis secondary to AB0 incompatible platelet products. An underrecognized transfusion reaction. Am J Clin Pathol 111: 202–206PubMedGoogle Scholar
  60. 60.
    McMilin KD, Johnson RL (1993) HLA homozygosity and the risk of related-donor transfusion-associated graft-vs. -host-disease. Transfus Med Rev 7: 37–41PubMedGoogle Scholar
  61. 61.
    Mollison PL (ed) (1983) Blood transfusion in clinical medicine, 7th edn. Blackwell, OxfordGoogle Scholar
  62. 62.
    Mollison PL, Engelfriet CP, Contreras M (eds) (1993) Blood transfusion in clinical medicine, 9th ed. Blackwell, OxfordGoogle Scholar
  63. 63.
    Mollison PL, Engelfriet CP, Contreras M (ed) (1997) Blood transfusion in clinical medicine. Blackwell, Oxford, 10. Aufl.Google Scholar
  64. 64.
    Mollison PL, Engelfriet CP, Contreras M (ed) (1997) Blood transfusion in clinical medicine, Kap. Red cell incompatibility in vivo, 10 th edn. Blackwell, Oxford, pp 315–35Google Scholar
  65. 65.
    Mori S, Matsushita H, Ozaki K, Ishida A, Tokuhira M, Nakajima H et al. (1995) Spontaneous resolution of transfusion-associated graft-vs. -host disease. Transfusion 35: 431–435PubMedGoogle Scholar
  66. 66.
    Morrison FS, Mollison PL (1966) Post-transfusion purpura. N Engl J Med 275: 243–248PubMedGoogle Scholar
  67. 67.
    Mueller-Eckhardt C (1986) Post-transfusion purpura. Br J Haematol 64: 419–424PubMedGoogle Scholar
  68. 68.
    Mueller-Eckhardt C, Kiefel V (1988) High-dose lgG for post-transfusion purpura — revisited. Blut 57: 163–167PubMedGoogle Scholar
  69. 69.
    Mueller-Eckhardt C, Kiefel V, Mueller-Eckhardt G et al. (1986) Posttransfusion purpura. A survey of 13 cases. Klin Wochenschr 64: 1198–1203PubMedGoogle Scholar
  70. 70.
    Mueller-Eckhardt C, Kroll H, Kiefel V und Mitglieder der »European PTP Study Group« (1991) Posttransfusion purpura. In: Kaplan-Gouet C, Schlegel N, Salmon C und McGregor J (eds) Platelet immunology: fundamental and clinical aspects. John Libbey Eurotext, Paris, pp 249–255Google Scholar
  71. 71.
    Mueller-Eckhardt C, Küenzlen E, Thilo-Körner D und Pralle H (1983) High-dose intravenous immunoglobulin for post-transfusion purpura [letter]. N Engl J Med 308: 287–287PubMedGoogle Scholar
  72. 72.
    Muylle L, Wouters E, Bock RD und Peetermans ME (1992) Reactions to platelet transfusion: the effect of the storage time of the concentrate. Transfus Med 2: 289–293PubMedGoogle Scholar
  73. 73.
    Ness PM, Shirey RS, Weinstein MH und King KE (2001) An animal model for delayed hemolytic transfusion reactions. Transfus Med Rev 15: 305–317PubMedGoogle Scholar
  74. 74.
    Nordhagen R, Conradi M, Dromtorp SM (1986) Pulmonary reaction associated with transfusion of plasma containing anti-5b. Vox Sanguinis 51: 102–107PubMedGoogle Scholar
  75. 75.
    Nydegger UE, Kazatchkine MD (1983) The role of complement in immune clearance of blood cells. Springer Semin Immunopathol 6: 373–398PubMedGoogle Scholar
  76. 76.
    Ohto H, Anderson KC (1996) Posttransfusion graft-vs. -host disease in Japanese newborns. Transfusion 36: 117–123PubMedGoogle Scholar
  77. 77.
    Perkins HA, Payne R, Ferguson J, Wood M (1966) Nonhemolytic febrile transfusion reactions. Quantitative effects of blood components with emphasis on isosnatigenic incompatibility of leukocytes. Vox Sanguinis 11: 578–600PubMedGoogle Scholar
  78. 78.
    Petz LD, Calhoun L, Shulman IA et al. (1997) The sickle cell hemolytic reaction syndrome. Transfusion 37: 382–392PubMedGoogle Scholar
  79. 79.
    Pineda AA, Taswell HF (1975) Transfusion reactions with Anti-lgA antibodies: report of four cases and review of the literature. Transfusion 15: 10–15PubMedGoogle Scholar
  80. 80.
    Popovsky MA, Abel MD, Moore SB (1983) Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. American Review of Respiratory Disease 128: 185–189PubMedGoogle Scholar
  81. 81.
    Popovsky MA, Moore SB (1985) Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 25: 573–577PubMedGoogle Scholar
  82. 82.
    Prince M, Szer J, van der Weyden MB et al. (1991) Transfusion associated graft-vs. -host disease after cardiac surgery: response to antithymocyte-globulin and corticosteroid therapy. Austr NZ J of Med 21: 43–46Google Scholar
  83. 83.
    Ramsey G (1991) Red cell antibodies arising from solid organ transplants. Transfusion 31: 76–86PubMedGoogle Scholar
  84. 84.
    Redman M, Regan F, Contreras M (1996) A prospective study of the incidence of red cell allo-immunization following transfusion. Vox Sanguinis 71: 216–220PubMedGoogle Scholar
  85. 85.
    Salama A, Mueller-Eckhardt C (1984) Delayed hemolytic transfusion reactions. Evidence for complement activation involving allogeneic and autologous red cells. Transfusion 24: 188–193PubMedGoogle Scholar
  86. 86.
    Salama A, Schwind P, Schonhage K et al. (2001) Rapid detection of antibodies to immunoglobulin A molecules by using the particle gel immunoassay. Vox Sanguinis 81: 45–48PubMedGoogle Scholar
  87. 87.
    Salmon JP, Michaux S, Hermanne JP et al. (1999) Delayed massive immune hemolysis mediated by minor AB0 incompatibility after allogeneic peripheral blood progenitor cell transplantation. Transfusion 39: 824–827PubMedGoogle Scholar
  88. 88.
    Sandler SG, Eckrich R, Malamut D, Mallory D (1994) Hemagglutination assays for the diagnosis and prevention of lgA anaphylactic transfusion reactions. Blood 84: 2031–2035PubMedGoogle Scholar
  89. 89.
    Sandler SG, Mallory D, Malamut D und Eckrich R (1995) lgA anaphylactic transfusion reactions. Transfus Med Rev 9: 1–8PubMedGoogle Scholar
  90. 90.
    Sazama K (1990) Reports of 355 transfusion-associated deaths: 1976 through 1985. Transfusion 30: 583–590PubMedGoogle Scholar
  91. 91.
    Schroeder ML (2002) Transfusion-associated graft-vs. -host disease. Br J Haematol 117: 275–287PubMedGoogle Scholar
  92. 92.
    Scott EP, Moilan-Bergeland J, Dalmasso AP (1988) Posttransfusion thrombocytopenia associated with passive transfusion of a platelet-specific antibody. Transfusion 28: 73–76PubMedGoogle Scholar
  93. 93.
    Seeger W, Schneider U, Kreusler B et al. (1990) Reproduction of transfusion-related acute lung injury in an ex vivo lung model. Blood 76: 1438–1444PubMedGoogle Scholar
  94. 94.
    Shimada E, Tadokoro K, Watanabe Y et al. (2002) Anaphylactic transfusion reactions in haptoglobin-deficient patients with lgE and lgG haptoglobin antibodies. Transfusion 42: 766–773PubMedGoogle Scholar
  95. 95.
    Shulman NR, Aster RH, Leithner A, Hiller MC (1961) Immunoreactions involving platelets. V. Post-transfusion purpura due to a complement-fixing antibody against a genetically controlled platelet antigen. A proposed mechanism for thrombocytopenia and its relevance in »autoimmunity«. Journal of Clinical Investigation 40: 1597–1620PubMedGoogle Scholar
  96. 96.
    Shulman NR, Jordan JV (1987) Platelet immunology. In: Colman RW, Hirsh J, Marder VJ, Salzman EW (eds) Hemostasis and thrombosis. Basic principles and practice. Lippincott, Philadelphia, S 452–529Google Scholar
  97. 97.
    Silliman CC (1999) Transfusion-related acute lung injury. Transfus Med Rev 13: 177–186PubMedGoogle Scholar
  98. 98.
    Silliman CC, Paterson AJ, Dickey WO et al. (1997) The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion 37: 719–726PubMedGoogle Scholar
  99. 99.
    Sloand EM, Fox SM, Banks SM, Klein HG (1990) Preparation of lgA-deficient platelets. Transfusion 30: 322–326PubMedGoogle Scholar
  100. 100.
    Spector JI, Crosby WH (1975) Coagulation studies during experimental hemoglobinemia in humans. J Appl Physiol 38: 195–198PubMedGoogle Scholar
  101. 101.
    Stack G, Judge JV, Snyder EL (1996) Febrile and nonimmune transfsion reactions. In: Rossi EC, Simon TL, Moss GS und Gould SA (eds) Principles of transfusion medicine, 2 nd edn. Williams &Wilkins, Baltimore, pp 773–784Google Scholar
  102. 102.
    Stricker RB, Lewis BH, Corash L, Shuman MA (1987) Posttransfusion purpura associated with an autoantibody directed against a previously undefined platelet antigen. Blood 69: 1458–1463PubMedGoogle Scholar
  103. 103.
    Taaning E, Jacobsen N, Morling N (1994) Graft-derived anti-HPA- 2b production after allogeneic bone-marrow transplantation. Br J Haematol 86: 651–653PubMedGoogle Scholar
  104. 104.
    Taaning E, Tonnesen F (1999) Pan-reactive platelet antibodies in post-transfusion purpura. Vox Sanguinis 76: 120–123PubMedGoogle Scholar
  105. 105.
    Valbonesi M, Luigi MCD, Lercari G et al. (2000) Acute intravascular hemolysis in two patients transfused with dry-platelet units obtained from the same AB0 incompatible donor. Int J Artif Organs 23: 642–646PubMedGoogle Scholar
  106. 106.
    Vamvakas EC, Pineda AA, Reisner R et al. (1995) The differentiation of delayed hemolytic and delayed serologic transfusion reactions: incidence and predictors of hemolysis. Transfusion 35: 26–32PubMedGoogle Scholar
  107. 107.
    Vichinsky EP, Earles A, Johnson RA et al. (1990) Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 322: 1617–1621PubMedGoogle Scholar
  108. 108.
    Vo TD, Cowles J, Heal JM, Blumberg N (2001) Platelet washing to prevent recurrent febrile reactions to leucocyte-reduced transfusions. Transfus Med 11: 45–47PubMedGoogle Scholar
  109. 109.
    Vyas GN, Perkins HA, Fudenberg HH (1968) Anaphylactoid transfusion reactions associated with anti-lgA. Lancet 2: 312–315PubMedGoogle Scholar
  110. 110.
    Walker DR, Branch DR, Dzik WH et al. (ed) (1993) Technical manual, 11 th edn. American Association of Blood Banks, BethesdaGoogle Scholar
  111. 111.
    Wallace J (ed) (1977) Blood transfusion for clinicians. Churchill Livingstone, EdinburghGoogle Scholar
  112. 112.
    Ward HN (1970) Pulmonary infiltrates associated with leukoagglutinin transfusion reactions. Ann Int Med 73: 689–694PubMedGoogle Scholar
  113. 113.
    Ward HN, Lipscomb TS und Cawley LP (1968) Pulmonary hypersensitivity reaction after blood transfusion. Archives of Internal Medicine 122: 362–366PubMedGoogle Scholar
  114. 114.
    Warkentin TE und Smith JW (1997) The alloimmune thrombocytopenic syndromes. Transfus Med Rev 11: 296–307PubMedGoogle Scholar
  115. 115.
    Warkentin TE, Smith JW, Hayward CPM et al. (1992) Thrombocytopenia caused by passive transfusion of anti-glycoprotein Ia/ IIa alloantibody (anti-HPA-5b). Blood 79: 2480–2484PubMedGoogle Scholar
  116. 116.
    Watkins NA, Smethurst PA, Allen D et al. (2002) Platelet (alpha) IIb(beta)3 recombinant autoantibodies from the B-cell repertoire of a post-transfusion purpura patient. Br J Haematol 116: 677 – 685PubMedGoogle Scholar
  117. 117.
    West KA, Anderson DR, McAlister VC et al. (1999) Alloimmune thrombocytopenia after organ transplantation. N Engl J Med 341: 1504–1507PubMedGoogle Scholar
  118. 118.
    Williamson LM, Lowe S, Love EM et al. (1999) Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. BMJ 319: 16–19PubMedGoogle Scholar
  119. 119.
    Win N, Peterkin MA, Watson WH (1995) The therapeutic value of HPA-1 a negative platelet transfusion in post-transfusion purpura complicated by life threatening haemorrhage. Vox Sanguinis 39: 138–139Google Scholar
  120. 120.
    Wolf CF, Canale VC (1976) Fatal pulmonary hypersensitivity reaction to HL-A incompatible blood transfusion: report of a case and review of the literature. Transfusion 16: 135–140PubMedGoogle Scholar
  121. 121.
    Yasukawa M, Shinozaki F, Hato T et al. (1994) Successful treatment of transfusion-associated graft-vs. -host disease. Br J Haematol 86: 831–836PubMedGoogle Scholar
  122. 122.
    Yomtovian R, Kline W, Press C et al. (1984) Severe pulmonary hypersensitivity associated with passive transfusion of a neutrophil-specific antibody. Lancet I: 244–246Google Scholar
  123. 123.
    Zabern IV, Ehlers M, Grunwald U et al. (1998) Release of mediators of systemic inflammatory response syndrome in the course of a severe delayed hemolytic transfusion reaction caused by anti-D. Transfusion 38: 459–468Google Scholar
  124. 124.
    Zupanska B, Uhrynowska M, Guz K et al. (2001) The risk of antibody formation against HNA 1 a and HNA 1 b granulocyte antigens during pregnancy and its relation to neonatal neutropenia. Transfus Med 11: 377–382PubMedGoogle Scholar
  125. 125.
    Zupanska B, Uhrynowska M, Konopka L (1999) Transfusion-related acute lung injury due to granulocyte-agglutination antibody in a patient with paroxysmal nocturnal hemoglobinuria. Transfusion 39: 944–947PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • V. Kiefel

There are no affiliations available

Personalised recommendations